Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Boos

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
Thrombosis Research|October 19, 2006
Assessment of mean platelet volume in coronary artery disease - what does it mean?Christopher J Boos, Gregory Y H Lip
Current Pharmaceutical Design|May 30, 2006
Is hypertension an inflammatory process?Christopher J Boos, Gregory Y H Lip
International Journal of Cardiology|December 29, 2016
Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulantLouise A E Brown, Christopher J Boos
Heart (British Cardiac Society)|January 16, 2008
Inflammation and atrial fibrillation: cause or effect?Christopher J Boos, Gregory Y H Lip
BMC Cardiovascular Disorders|March 17, 2021
The relationship between ambulatory arterial stiffness, inflammation, blood pressure dipping and cardiovascular outcomesChristopher J Boos, Lin-Thiri Toon, Halah Almahdi
BMJ (Clinical Research Ed.)|June 28, 2003
Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm controlChristopher J Boos, Ranjit S More, Jorg Carlsson
Heart Failure Reviews|June 26, 2013
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failureChristopher J Boos, Michael Nam, A J Camm
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Management of amiodarone-related thyroid problemsShashithej K Narayana, David R Woods, Christopher J Boos
Cardiology in the Young|February 20, 2009
A technique to overcome high defibrillation thresholds for an implantable cardioverter defibrillatorChristopher J Boos, Andrew J Bentall, Howard J Marshall
International Journal of Cardiology|February 23, 2013
Successful use of trastuzumab following cardiac resynchronisation therapySimon Claridge, Amit Chakrabarti, Kim Greaves, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
Thrombosis Research|October 19, 2006
Assessment of mean platelet volume in coronary artery disease - what does it mean?Christopher J Boos, Gregory Y H Lip
Current Pharmaceutical Design|May 30, 2006
Is hypertension an inflammatory process?Christopher J Boos, Gregory Y H Lip
International Journal of Cardiology|December 29, 2016
Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulantLouise A E Brown, Christopher J Boos
Heart (British Cardiac Society)|January 16, 2008
Inflammation and atrial fibrillation: cause or effect?Christopher J Boos, Gregory Y H Lip
BMC Cardiovascular Disorders|March 17, 2021
The relationship between ambulatory arterial stiffness, inflammation, blood pressure dipping and cardiovascular outcomesChristopher J Boos, Lin-Thiri Toon, Halah Almahdi
BMJ (Clinical Research Ed.)|June 28, 2003
Persistent atrial fibrillation: rate control or rhythm control. Rate control is not inferior to rhythm controlChristopher J Boos, Ranjit S More, Jorg Carlsson
Heart Failure Reviews|June 26, 2013
Novel oral anticoagulants and stroke prevention in atrial fibrillation and chronic heart failureChristopher J Boos, Michael Nam, A J Camm
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Management of amiodarone-related thyroid problemsShashithej K Narayana, David R Woods, Christopher J Boos
Cardiology in the Young|February 20, 2009
A technique to overcome high defibrillation thresholds for an implantable cardioverter defibrillatorChristopher J Boos, Andrew J Bentall, Howard J Marshall
International Journal of Cardiology|February 23, 2013
Successful use of trastuzumab following cardiac resynchronisation therapySimon Claridge, Amit Chakrabarti, Kim Greaves, et al.
Pageof 11